TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up
NCT ID: NCT00336284
Last Updated: 2010-08-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
1450 participants
INTERVENTIONAL
2005-11-30
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home-Monitoring in Implantable Cardioverter Defibrillator (ICD) Patients
NCT00787683
TRIAGE-CRT Telemonitoring in Patients With CHF and Indication of CRT-D
NCT00395642
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
NCT00559988
ProMRI ICD/CRT-D Post Approval Study
NCT02933619
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
NCT00538356
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home Monitoring
Home Monitoring programmed on.
Home Monitoring
Home Monitoring programmed on. In-office and Home Monitoring evaluation at 3 and 15 months post ICD implant. Home Monitoring evaluation only at 6, 9, and 12 months post ICD implant.
In-Office Conventional Follow-up
Home Monitoring programmed off.
In-Office Conventional Follow-up
Home Monitoring programmed off. In-office evaluations at 3, 6, 9, 12, and 15 months post ICD implant.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home Monitoring
Home Monitoring programmed on. In-office and Home Monitoring evaluation at 3 and 15 months post ICD implant. Home Monitoring evaluation only at 6, 9, and 12 months post ICD implant.
In-Office Conventional Follow-up
Home Monitoring programmed off. In-office evaluations at 3, 6, 9, 12, and 15 months post ICD implant.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to utilize the HM system throughout the study
* Ability to give informed consent
* Geographically stable and able to return for regular follow-ups for fifteen (15) months
* At least 18 years old
* Pacemaker dependent
* Currently enrolled in any other cardiac clinical investigation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biotronik, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
BIOTRONIK, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Niraj Varma, MD, FRCP
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site 55
Birmingham, Alabama, United States
Site 68
Mesa, Arizona, United States
Site 99
Phoenix, Arizona, United States
Site 118
Bakersfield, California, United States
Site 91
Bakersfield, California, United States
Site 95
Burbank, California, United States
Site 72
Fairfield, California, United States
Site 43
Fremont, California, United States
Site 90
Fresno, California, United States
Site 73
Fresno, California, United States
Site 75
Fresno, California, United States
Site 67
Glendale, California, United States
Site 82
Jackson, California, United States
Site 78
Mission Viejo, California, United States
Site 15
Sherman Oaks, California, United States
Site 89
Simi Valley, California, United States
Site 88
Whittier, California, United States
Site 37
Boulder, Colorado, United States
Site 38
Boulder, Colorado, United States
Site 98
Denver, Colorado, United States
Site 122
Newark, Delaware, United States
Site 100
Brooksville, Florida, United States
Site 111
Jacksonville, Florida, United States
Site 40
Lakeland, Florida, United States
Site 36
Lauderdale Lakes, Florida, United States
Site 34
Miami, Florida, United States
Site 42
Oakland Park, Florida, United States
Site 13
Port Charlotte, Florida, United States
Site 41
Tamarac, Florida, United States
Site 60
Vero Beach, Florida, United States
Site 6
Canton, Georgia, United States
Site 106
Douglas, Georgia, United States
Site 61
Lawrenceville, Georgia, United States
Site 10
Marietta, Georgia, United States
Site 66
Marietta, Georgia, United States
Site 21
Chicago, Illinois, United States
Site 124
Chicago, Illinois, United States
Site 39
Oak Lawn, Illinois, United States
Site 3
Louisville, Kentucky, United States
Site 11
Owensboro, Kentucky, United States
Site 51
Covington, Louisiana, United States
Site 79
Hammond, Louisiana, United States
Site 85
Lacombe, Louisiana, United States
Site 102
Lafayette, Louisiana, United States
Site 2
Lake Charles, Louisiana, United States
Site 53
New Orleans, Louisiana, United States
Site 17
Annapolis, Maryland, United States
Site 25
Lanham, Maryland, United States
Site 17
Riverdale, Maryland, United States
Site 18
Rockville, Maryland, United States
Site 29
Boston, Massachusetts, United States
Site 94
Ann Arbor, Michigan, United States
Site 103
Bloomfield Hills, Michigan, United States
Site 4
Lansing, Michigan, United States
Site 12
Lapeer, Michigan, United States
Site 22
Saginaw, Michigan, United States
Site 14
Corinth, Mississippi, United States
Site 52
Gulfport, Mississippi, United States
Site 49
Bridgeton, Missouri, United States
Site 105
Festus, Missouri, United States
Site 121
Festus, Missouri, United States
Site 45
Moberly, Missouri, United States
Site 56
Osage Beach, Missouri, United States
Site 108
St Louis, Missouri, United States
Site 114
St Louis, Missouri, United States
Site 48
St Louis, Missouri, United States
Site 113
St Louis, Missouri, United States
Site 74
St Louis, Missouri, United States
Site 47
University City, Missouri, United States
Site 117
Brick, New Jersey, United States
Site 120
East Brunswick, New Jersey, United States
Site 107
East Orange, New Jersey, United States
Site 119
Elizabeth, New Jersey, United States
Site 116
Oakhurst, New Jersey, United States
Site 71
Wayne, New Jersey, United States
Site 97
Las Cruces, New Mexico, United States
Site 112
Batavia, New York, United States
Site 19
Brooklyn, New York, United States
Site 27
Brooklyn, New York, United States
Site 26
Brooklyn, New York, United States
Site 77
Brooklyn, New York, United States
Site 9
Johnson City, New York, United States
Site 35
New York, New York, United States
Site 76
New York, New York, United States
Site 115
Pinehurst, North Carolina, United States
Site 57
Cleveland, Ohio, United States
Site 16
Columbus, Ohio, United States
Site 50
Columbus, Ohio, United States
Site 84
Fairview Park, Ohio, United States
Site 93
Massillon, Ohio, United States
Site 30
Middletown, Ohio, United States
Site 87
Middletown, Ohio, United States
Site 96
Tulsa, Oklahoma, United States
Site 63
Chinchilla, Pennsylvania, United States
Site 62
Clarks Summit, Pennsylvania, United States
Site 32
Upland, Pennsylvania, United States
Site 23
Columbia, South Carolina, United States
Site 20
Florence, South Carolina, United States
Site 109
Lancaster, South Carolina, United States
Site 5
Rock Hill, South Carolina, United States
Site 59
Knoxville, Tennessee, United States
Site 8
Knoxville, Tennessee, United States
Site 110
Tullahoma, Tennessee, United States
Site 1
Amarillo, Texas, United States
Site 81
Brownsville, Texas, United States
Site 33
Odessa, Texas, United States
Site 80
San Antonio, Texas, United States
Site 7
Yakima, Washington, United States
Site 104
Toronto, Ontario, Canada
Site 92
Fleurimont, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Varma N, Epstein AE, Irimpen A, Schweikert R, Love C; TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010 Jul 27;122(4):325-32. doi: 10.1161/CIRCULATIONAHA.110.937409. Epub 2010 Jul 12.
Chew DS, Piccini JP, Au F, Frazier-Mills CG, Michalski J, Varma N; TRUST Investigators. Alert-driven vs scheduled remote monitoring of implantable cardiac defibrillators: A cost-consequence analysis from the TRUST trial. Heart Rhythm. 2023 Mar;20(3):440-447. doi: 10.1016/j.hrthm.2022.12.003. Epub 2022 Dec 8.
Varma N, Love CJ, Michalski J, Epstein AE; TRUST Investigators. Alert-Based ICD Follow-Up: A Model of Digitally Driven Remote Patient Monitoring. JACC Clin Electrophysiol. 2021 Aug;7(8):976-987. doi: 10.1016/j.jacep.2021.01.008. Epub 2021 Feb 24.
Varma N, Love CJ, Schweikert R, Moll P, Michalski J, Epstein AE; TRUST Investigators. Automatic remote monitoring utilizing daily transmissions: transmission reliability and implantable cardioverter defibrillator battery longevity in the TRUST trial. Europace. 2018 Apr 1;20(4):622-628. doi: 10.1093/europace/eux059.
Varma N, Epstein AE, Schweikert R, Michalski J, Love CJ; TRUST Investigators. Role of Automatic Wireless Remote Monitoring Immediately Following ICD Implant: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial. J Cardiovasc Electrophysiol. 2016 Mar;27(3):321-6. doi: 10.1111/jce.12895. Epub 2016 Jan 27.
Varma N, Michalski J, Stambler B, Pavri BB; TRUST Investigators. Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations. Eur Heart J. 2014 May 21;35(20):1345-52. doi: 10.1093/eurheartj/ehu066. Epub 2014 Mar 3.
Varma N, Pavri BB, Stambler B, Michalski J; TRUST Investigators. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems. Europace. 2013 May;15(5):697-703. doi: 10.1093/europace/eus410. Epub 2012 Dec 19.
Varma N, Michalski J, Epstein AE, Schweikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ Arrhythm Electrophysiol. 2010 Oct;3(5):428-36. doi: 10.1161/CIRCEP.110.951962. Epub 2010 Aug 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20052069
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.